SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kariyawasam, S. H.
Right arrow Articles by Handley, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kariyawasam, S. H.
Right arrow Articles by Handley, S. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Quinolinic acid inhibits DOI-induced head shakes in mice

S. Himani Kariyawasam

Sheila L. Handley

Pharmacology Research, Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK

Quinolinic acid, a metabolite of tryptophan in the kynurenine pathway, inhibited the 5-HT2A/2C direct agonist (+)-1-(2,5-dimethoxy-4-iodophenyl)-2-amino propane hydrochloride (DOI) induced head shakes in mice in a dose-dependent manner. This e¡ect was observed 10 min after intracerebroventricular (i.c.v.) administration of 0.06251 mg/mouse. 3-Hydroxyanthranilic acid, which is the immediate stable precursor of quinolinic acid in the kynurenine pathway, showed a similar e¡ect 60120 min after subcutaneous (s.c.) administration, without showing any e¡ect 10 min after i.c.v. administration or 2040 min after s.c. administration. These observations suggest that quinolinic acid can alter central e¡ects mediated via 5-HT2A receptors.

Key Words: DOI • head shakes • 5-HT2A receptor • kynurenine • quinolinic acid

Journal of Psychopharmacology, Vol. 13, No. 3, 284-285 (1999)
DOI: 10.1177/026988119901300311


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement